key: cord-0334310-arml4w8b
authors: Deutsch, Jessica M; Jaiyesimi, Olakunle; Pitts, Kelly; Houk, Jay; Ushijima, Blake; Walker, Brian K.; Paul, Valerie J.; Garg, Neha
title: Metabolomics of healthy and stony coral tissue loss disease affected Montastraea cavernosa corals
date: 2021-08-19
journal: bioRxiv
DOI: 10.1101/2021.08.18.456681
sha: 15f9e8671f687d71409461488513cfda5051b9d2
doc_id: 334310
cord_uid: arml4w8b

Stony coral tissue loss disease, first observed in Florida in 2014, has now spread along the entire Florida Reef Tract and on reefs in many Caribbean countries. The disease affects a variety of coral species with differential outcomes, and in many instances results in whole-colony mortality. We employed untargeted metabolomic profiling of Montastraea cavernosa corals affected by stony coral tissue loss disease to identify metabolic markers of disease. Herein, extracts from apparently healthy, diseased, and recovered corals, Montastraea cavernosa, collected at a reef site near Ft. Lauderdale, Florida were subjected to liquid-chromatography mass spectrometry-based metabolomics. Unsupervised principal component analysis reveals wide variation in metabolomic profiles of healthy corals of the same species, which differ from diseased corals. Using a combination of supervised and unsupervised data analyses tools, we describe metabolite features that explain variation between the apparently healthy corals, between diseased corals, and between the healthy and the diseased corals. By employing a culture-based approach, we assign sources of a subset of these molecules to the endosymbiotic dinoflagellates, Symbiodiniaceae. Specifically, we identify various endosymbiont-specific lipid classes, such as betaine lipids, glycolipids, and tocopherols, which differentiate samples taken from apparently healthy corals and diseased corals. Given the variation observed in metabolite fingerprints of corals, our data suggests that metabolomics is a viable approach to link metabolite profiles of different coral species with their susceptibility and resilience to numerous coral diseases spreading through reefs worldwide.

Corals are holobionts consisting of the coral animal, photosynthetic dinoflagellate 39 endosymbionts (family Symbiodiniaceae) commonly referred to as zooxanthellae, and a complex 40 microbiome (Rohwer et Thurber et al., 2020). One of the challenges with pathogen-identification is the inherent within-species 54 (intra) and between-species (inter) variability to disease susceptibility. Understanding intraspecies and 55 interspecies variability in genotypes, metabolomes, microbiomes, and other physiological factors such 56 as bleaching history of field corals is critical to investigating their contribution to disease resistance 57 and susceptibility, which are essential to effective management and restoration efforts. 58

Caribbean coral reefs are experiencing an ongoing outbreak of a tissue loss disease named stony 59 coral tissue loss disease (SCTLD), which first appeared along the Florida Reef Tract in 2014 (Miller 60 et al., 2016; Walton et al., 2018; Muller et al., 2020) and continues to spread throughout various genotype, the endosymbiont genotype (Symbiodiniaceae), the associated microbiome, the 86 environment, previous history of bleaching, and disease (Muscatine, 1990; Baker, 2003; Roth, 2014; 87 LaJeunesse et al., 2018). Recent application of metabolomics studies on coral holobionts and their 88 approach to co-analyze the metabolomes of three Symbiodiniaceae species to reveal that at least a third 110 of the top metabolites separating the field coral sample groups belonged to Symbiodiniaceae. We 111 identify a number of Symbiodiniaceae metabolites using a suite of recently developed metabolite 112 feature annotation tools. This study highlights that the culture-based approach, when combined with 113 metabolomics, facilitates an understanding of the contribution of different holobiont components to the 114 metabolomic profiles, which can aid in teasing apart the source of metabolites that dictate the 115 separation in metabolomic profiles. We propose that in addition to the prominent contribution of 116 Symbiodiniaceae to metabolomes of field corals, careful cataloging of host genotype and past 117 environmental insults is important to understand intraspecies differences of field corals. 118

Site selection. An experimental site was set up on March 23, 2020 located 475 m from shore (26° 9.05' 121 N, 80° 5.75' W), on the Broward-Miami Ecoregion Ridge-Shallow habitat (Walker et al., 2008; 122 Walker, 2012 ) in about 7 m depth ( Figure 1 ). Nineteen visibly diseased Montastraea cavernosa 123 colonies were tagged, photographed, and mapped across a 100m x 35m area of hardbottom using a 124 floating GPS to obtain coordinates for all colonies. Healthy-looking colonies were not mapped. 125

Collections were delayed due to the coronavirus pandemic. This site was revisited August 19, 2020 to 126 evaluate disease progression and sample corals. At this time, 6 newly diseased colonies were 127 additionally sampled and three previously diseased colonies no longer showed signs of disease 128 (apparently recovered). Thus, 22 diseased colonies and 3 recovered colonies were sampled in August. 129

On October 14, 2020, three new diseased colonies and ten colonies completely covered in seemingly 130 healthy tissue were added to the site and sampled for metabolomics.

Sampling and extraction procedure for coral samples. The samples were collected by divers on 132 SCUBA with a 10 mL needleless syringe by agitating 4-5 adjacent polyps with the tip of the syringe. 133

Dislodged tissue fragments and mucus were slowly drawn into the syringe until 10 mL of sample was 134 collected. Diseased colonies were sampled along the disease lesion. Recovered colonies that displayed 135 signs of SCTLD in March 2020, but no longer appeared to be diseased were sampled at the furthest 136 point away from the former disease lesion to sample an area that was least likely to be impacted by 137 SCTLD. For healthy corals, colonies that were completely covered in apparently healthy tissue were 138 chosen to ensure that they were less likely to have had SCTLD or other tissue loss. All samples were 139 then placed in 15 mL conical tubes, frozen and lyophilized. 140

After weighing, the lyophilized samples were transferred to a 20 mL scintillation vial for 141 extraction. To each conical tube, 6 mL of 2:1 methanol (MeOH): H2O was added to dissolve any 142 residual material left in the tube and transferred to the scintillation vial containing the lyophilized 143 sample. To this vial, 4 mL of ethyl acetate (EtOAc) was added, and the samples were extracted (10 ml 144 of 2:2:1 EtOAc: MeOH: H2O) for 4 h at 23 °C. The extracts were spun in a Savant SpeedVac for 10 145 min, and the supernatant was transferred to a 7 mL glass vial (precleaned three times with MEOH). 146

The solvent was removed in vacuo using the Savant SpeedVac set at 35 °C and then lyophilized at -45 147 °C to remove any remaining water. The concentrate was transferred back into the initial falcon tube in 148 4 mL of 3:1 MeOH: H2O and centrifuged at 4500×g for 10 min to remove particulates. For 149 metabolomics, 0.5 mL of the supernatant was transferred to a pre-weighed 1.5 mL microcentrifuge 150 tube, centrifuged, and lyophilized. The remaining supernatant was transferred back to the 7 mL 151 scintillation vial and dried in vacuo. The samples were stored at -20 °C until LC-MS data was acquired. 152

Sampling and extraction procedure for cultured endosymbionts. Symbiodiniaceae with 20 µE of light on a 14:10 diurnal cycle. To prepare extracts, 500 µl of each culture was transferred 158 to a 1.5 mL microcentrifuge tube. Cells were pelletized at 500×g for 5 min to remove media and then 159 washed twice with seawater filtered through a 0.22 µm -pore membrane filter (FSW). A sample of 0.2 160 µm-filtered seawater (500 µL) was extracted in tandem as a control. The washed pellet was 161 resuspended in 100 µL of HPLC grade water for transfer into a pre-cleaned 7 mL scintillation vial and 162 then frozen and lyophilized. Samples were extracted overnight at -20 °C in 4 mL of 2:2:1 EtOAc: 163

MeOH:H2O. Solvents were removed on a SpeedVac at 35 °C for 4 h. The dried samples were 164 resuspended in 3:1 MeOH:H2O and transferred into a 1.5 mL microcentrifuge tube. The samples were 165 centrifuged at 4500×g for 10 min, and the supernatant was transferred to the pre-weighed 166 microcentrifuge tube. This supernatant was removed via SpeedVac for 3 h after which the concentrated 167 extract was frozen, then lyophilized. The weight of lyophilized extract was recorded. 168

Mass Spectrometry Data Acquisition and analyses. All dried extracts were resuspended in 100% 169

MeOH (LC-MS grade) containing 1 µM of sulfadimethoxine as an internal standard. The samples were 170 analyzed with an Agilent 1290 Infinity II UHPLC system (Agilent Technologies) using a Kinetex 1.7 171 μm C18 reversed phase UHPLC column (50×2.1 mm) coupled to an ImpactII ultrahigh resolution Qq-172 TOF mass spectrometer (Bruker Daltonics, GmbH, Bremen, Germany) equipped with an ESI source 173 for MS/MS analysis. MS spectra were acquired in positive ionization mode, m/z 50-2000 Da. An active 174 exclusion of two spectra was used, implying that an MS 1 ion would not be selected for fragmentation 175 after two consecutive MS 2 spectra had been recorded for it in a 0.5 min time window. The exclusion 176 was reconsidered and additional MS 2 spectra was acquired if five-fold enhancement in intensity was 177 observed. The eight most intense ions per MS 1 spectra were selected for further acquisition of MS 2 178 data. The chromatography solvent A: H2O + 0.1% v/v formic acid and solvent B: MeCN + 0.1% v/v formic acid were employed for separation. Flow rate was held constant at 0.5 mL/min throughout the 180 run. The gradient applied for chromatographic separation was 5% solvent B and 95% solvent A for 3 181 min, a linear gradient of 5% B-95% B over 17 min, held at 95% B for 3 min, 95% B-5% B in 1 min, 182 and held at 5% B for 1 min, 5%B-95%B in 1 min, held at 95% B for 2 min, 95%B-5%B in 1 min, then 183 held at 5%B for 2.5 min at a flow rate of 0.5 mL/min throughout. A mixture of 6-compounds 184 (amitryptiline, sulfamethazine, sulfamethizole, sulfachloropyridazine, sulfadimethoxine, coumarin-185 314) was run as quality control every 8 samples to ensure consistent instrument and column 186 performance. 187

The raw data was converted to mzXML format using vendor software and preprocessed on 188 MZmine 2.53 using mass detection, chromatogram building, chromatogram deconvolution, isotopic 189 grouping, retention time alignment, duplicate removal, and missing peak filling (Pluskal et al., 2010) . Prior to statistical analysis, blank subtraction was performed on the quantification tables using a Juptyer 226 notebook, available at GitHub -Garg-Lab/Jupyter-Notebook-Blank-Subtraction-Broward-County-227

Corals. The mean of each feature in the samples is compared separately to the mean of the feature in 228 the solvent controls and LC-MS blanks. A feature is retained if its sample mean is greater than 0.25 × 229 the mean of the sample in the blanks. The entire quantification table is exported, with each feature 230 marked as "true" (feature is retained) or "false" (feature is not retained). Visualization of the molecular 231 network, metadata mapping, and feature filtering was performed using Cytoscape (v 3.7.2) (Shannon 232 et al., 2003) . Within Cytoscape, node filtering was performed using metadata and quantification tables 233 and the nodes corresponding to features present in blank were removed. All Euler diagrams were The software PRIMER version 7 was used to test similarities in metabolite species between sampled 240 corals with differing health conditions. Cluster analyses with SIMPROF tests and non-metric multi-241 dimensional scaling (MDS) plots were constructed from a Bray-Curtis similarity matrix of log 242 transformed metabolite data. The metabolite similarities between corals using the coral condition status 243 at the time of sampling were tested using analyses of similarities (ANOISM). The similarity 244 percentages (SIMPER) were calculated for each cluster to identify the metabolites most responsible 245 for the differences between those clusters with 94% similarity. The purple and orange highlighted branches and circles were colonies in the same HCA sub-cluster, 336 but were not directly connected. Some colonies in these branches were also in close spatial proximity. 337

Based on the two clusters observed in HCA ( Figure 4A branches 4 and 6) , the healthy samples were 338 colored in green and blue in the PCA plot in Figure 3B . The clustering patterns were reproducible for 339 diseased corals when analyses was performed on data generated on diseased samples only 340 (Supplementary Figure 3C) . 341

The non-metric multi-dimensional scaling (MDS) plots divided the samples into eight distinct 342 clusters ( Figure 4B ). Categorizing the corals by the 94% similarity clusters in the map revealed no obvious large-scale spatial clustering. Many colonies with similar metabolite communities were spread 344 throughout the site and spatially comingled with dissimilar colonies. However, some neighboring 345 colony pairs were close in similarity indicating potential within-MDS-cluster spatial patterns. For 346 example, MDS cluster A indicated colonies 1 and 2 were most similar to each other and furthest away 347 from the other colonies in the similarity group, which was also the case in the map. So was the case 348

with cluster E colonies 7 and 8. However there were many more cases where colonies with dissimilar 349 metabolite communities were in close spatial proximity. 

In this study, we employed metabolomic profiling to visualize intraspecies variation of M. 511 cavernosa corals with no visual sign of disease, corals that apparently recovered, and corals presumably 512 with SCTLD. The unsupervised PCA, HCA, and MDS revealed metabolomic variation within healthy 513 corals, diseased corals, and between healthy and diseased corals, which was attributed to various 514 metabolites including lipids and tocopherols produced by Symbiodiniaceae. In many instances, the 515 healthy samples that clustered closer in PCA and HCA plots were also immediate neighbors in the site 516 map. Thus, the proximity resulted in similar metabolomes in most cases with a few exceptions. This 517 observation was not true for most diseased colonies, which showed wider spread in metabolomic 518 profiles in the PCA plot. In the future, time series experimental design for disease progression, along 519 with characterization of host genotype, symbiont genotype, and microbiome structure is important to 520 explain the source of this variability in the metabolomic profiles. 521

The emerging approaches in metabolomics technology allow analyses of hundreds to thousands 522 of metabolites. The major bottleneck in data analyses in metabolomics stems from our inability to 523 annotate the metabolites detected and to assign the biological source of the metabolite to an individual 524 holobiont partner. In the absence of comprehensive mass spectral databases for coral metabolites, 525 annotations were made using in silico methods and literatures searches. These compound annotations 526 were propagated to additional unknown metabolite features through a feature based molecular 527 networking approach and by discovery of sub-structural motifs using MS2LDA. Thus, we demonstrate 528 that use of in silico tools serve as a practical approach in the absence of databases to aid and improve 529 metabolite identifications for profiling of coral holobionts. Better understanding of holobiont response 530 to disease can be gleaned if metabolomics variation can be further assigned to the respective partner in 531 the holobiont. In this work, we highlight a feature based molecular networking approach to 532 metabolomics data acquired on cultured Symbiodiniaceae and the holobiont to assign sources of detected metabolites for the first time. Using this strategy, we annotated various top features describing 534 metabolomics variation to Symbiodiniaceae demonstrating the usefulness of this approach. A caveat 535 of this culture-based approach is that not all metabolites relevant in the holobiont may be produced in 536 culture. A tedious approach to overcome this limitation is to culture the symbionts under different 537 growth conditions such as temperature variation, nutrient limitation, etc. to induce production of 538 metabolites otherwise observed in a holobiont. In addition, direct extraction of metabolites from the 539 relatively pure fraction of in-hospite Symbiodiniaceae isolated from the coral should be applied for 540 direct comparison. Indeed, this approach has been used previously to describe lipid composition of 541 different species of Symbiodiniaceae under temperature stress. Once the source of a metabolite is 542 assigned to the holobiont partner, genomics can be employed to decipher the biochemical pathways 543 and their regulatory mechanisms. As additional metabolomic datasets become available on cultured 544 coral holobiont partners including cultured bacteria, such analyses will continue to provide biochemical 545 insights into the workings of a coral holobiont. Thus, linking metabolites to their biological producer 546 through comparative metabolomics in a coral holobiont is an important next step in understanding 547 symbiosis in corals and its disruption during disease and environmental stress. 548 MetaboAnalyst. The scale bar represents log-transformed intensity of these lipids. This figure  623 illustrates a subset of glycolipids. A comprehensive list of all glycolipids and the heat map for these 624 features is provided in Supplementary Table 3 study are provided in Supplementary Figures 7 and 8. (B) 

Pathogenesis of a tissue loss disease affecting multiple species of corals along the Florida reef 669 tract. Front

The 671 coral core microbiome identifies rare bacterial taxa as ubiquitous endosymbionts

A rapid spread of the stony coral tissue loss disease outbreak in the 675 Mexican Caribbean

Evaluation of sample preparation methods for the analysis of reef-building corals using 1H-678 NMR-based metabolomics

Flexibility and specificity in coral-algal symbiosis: diversity, ecology, and 680 biogeography of Symbiodinium

Stony Coral Tissue Loss Disease 683 biomarker bacteria identified in corals and overlying waters using a rapid field-based 684 sequencing approach. bioRxiv

Biodiversity increases ecosystem 686 functions despite multiple stressors on coral reefs

Functional evaluation 689 of marine-derived tocopherol, a minor homolog of vitamin E, on adipocyte differentiation and 690 inflammation using 3T3-L1 and RAW264.7 cells

The total economic value of U.S. coral reefs : a 693 review of the literature

Life-saving products from coral reefs

Polymorphism in a common Atlantic 696 reef coral (Montastraea cavernosa) and its long-term evolutionary implications

Learning mass spectrometry fragmentation of small molecules

Using metaboAnalyst 4.0 for comprehensive and 702 integrative metabolomics data analysis

Symbiodinium 705 associations with diseased and healthy scleractinian corals

Genomic determinants of coral heat tolerance across latitudes

ClassyFire: 711 automated chemical classification with a comprehensive, computable taxonomy

Molecular 714 and geochemical perspectives on the influence of CO2 on calcification in coral cell cultures

SIRIUS 4: a rapid tool for turning tandem mass spectra into metabolite structure information

Systematic classification of unknown metabolites using high-resolution fragmentation mass 721 spectra

Reef-scale impacts of the stony coral 724 tissue loss disease outbreak

Effects of the stony coral tissue loss disease outbreak on coral communities 727 and the benthic composition of cozumel reefs

Species richness on coral reefs and the pursuit of convergent global estimates

Three-733 dimensional microbiome and metabolome cartography of a diseased human lung

Metabolomics of a superorganism

Symbiodinium-invertebrate symbioses and the role of 738 metabolomics

Extraction protocol for nontargeted NMR and 740 LC-MS metabolomics-based analysis of hard coral and their algal symbionts

Interactive XCMS Online: simplifying advanced metabolomic data processing and 744 subsequent statistical analyses

Coral physiology and microbiome dynamics under combined warming and ocean 747 acidification

Ecological consequences of stony 749 coral tissue loss disease in the Turks and Caicos Islands

Metabolite 752 profiling of symbiont and host during thermal stress and bleaching in the coral Acropora 753 aspera

Coral reef ecosystems 755 under climate change and ocean acidification

Annual outbreaks of 758 coral disease coincide with extreme seasonal warming

Effect of high temperature on 761 the lipid composition of Isochrysis galbana Parke in logarithmic phase

The model organism as a system: integrating 'omics' data sets

Gene expression plasticity as a mechanism of coral adaptation 766 to a variable environment

Marine natural products. XXIX

four diacylglyceroglycolipids possessing ω3-769 polyunsaturated fatty acid residues, from the raphidopycean dinoflagellate Heterosigma 770 akashiwo

Map of Coral Cover of Susceptible Coral Species to 772 SCTLD

Systematic revision of Symbiodiniaceae highlights the antiquity and diversity of coral 775 endosymbionts

Stony 777 coral tissue loss disease in Florida is associated with disruption of host-zooxanthellae 778 physiology

Squishy lipids: Temperature effects 780 on the betaine and galactolipid profiles of a C18/C18 peridinin-containing dinoflagellate, 781 Symbiodinium microadriaticum (Dinophyceae), isolated from the mangrove jellyfish, 782 Cassiopea xamachana

The lipid biochemistry of 784 eukaryotic algae

Responses of coral-associated bacterial 786 communities to heat stress differ with Symbiodinium type on the same coral host

Metabolomic profiles differ among unique genotypes of a threatened Caribbean coral

Intracellular bacteria are common and taxonomically diverse in cultured and in hospite algal 793 endosymbionts of coral reefs

Limitations of using cultured algae to study cnidarian-algal 795 symbioses and suggestions for future studies

Metabolite pools of the reef building coral Montipora capitata are unaffected by 798 Symbiodiniaceae community composition

Projections of climate conditions that increase coral disease susceptibility and pathogen 802 abundance and virulence

Differences in cystic fibrosis-associated Burkholderia spp. bacteria metabolomes after 805 exposure to the antibiotic trimethoprim

Molecular and microbial microenvironments in chronically diseased lungs associated with 812 cystic fibrosis

Disentangling causation: complex roles of coral-associated 814 microorganisms in disease

Microbial community shifts associated with the ongoing stony coral tissue loss disease 818 outbreak on the Florida reef tract

eulerAPE: Drawing Area-Proportional 3-Venn Diagrams Using 821 Ellipses

The roles and interactions of symbiont, host and environment in defining coral 824 fitness

Detecting 826 sedimentation impacts to coral reefs resulting from dredging the Port of

Systematic review and meta-829 analysis of 50 years of coral disease research visualized through the scope of network theory

Spatial epidemiology of the 832 Stony-Coral-Tissue-Loss disease in Florida

The role of symbiotic algae in carbon and energy flux in reef corals

Studies on polyketide metabolites 837 of a symbiotic dinoflagellate, Symbiodinium sp.: A new C30 marine alkaloid 838 zooxanthellamine, a plausible precursor for zoanthid alkaloids

Effectiveness of topical 841 antibiotics in treating corals affected by Stony Coral Tissue Loss Disease

Feature-844 based molecular networking in the GNPS analysis environment

Coral metabolite 847 gradients affect microbial community structures and act as a disease cue

Projecting coral reef futures 850 under global warming and ocean acidification

Intraspecific diversity among partners drives functional variation in coral symbioses

Metabolomics: the apogee of the omics trilogy

The diversity of coral reefs: 858 what are we missing?

MZmine 2: Modular framework 860 for processing, visualizing, and analyzing mass spectrometry-based molecular profile data

Unprecedented 863 disease-related coral mortality in southeastern Florida

Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome

Metabolomics of reef benthic interactions reveals a bioactive lipid involved in coral 870 defence

The skeletal proteome of the coral Acropora millepora: The evolution of calcification by co-873 option and domain shuffling

The value of US coral reefs for flood risk reduction

Coral diseases: what is really known?

Metabolomic 881 signatures of coral bleaching history

A 883 multiomic analysis of in situ coral-turf algal interactions

Coral reef diseases in the Atlantic-Caribbean

Diversity and distribution of coral-889 associated bacteria

Rhodobacterales 891 and Rhizobiales are associated with Stony Coral Tissue Loss Disease and its suspected 892 sources of transmission

Microbial diseases of corals and global warming

Lipidome 896 analysis of Symbiodiniaceae reveals possible mechanisms of heat stress tolerance in reef coral 897 symbionts

The engine of the reef: photobiology of the coral-algal symbiosis

Symbiodinium clades A 901 and D differentially predispose Acropora cytherea to disease and Vibrio spp

Coral and Coral-904 Associated Microorganisms: A Prolific Source of Potential Bioactive Natural Products

Cytoscape: a 907 software environment for integrated models of biomolecular interaction networks

Assessing the effectiveness of two intervention 910 methods for stony coral tissue loss disease on Montastraea cavernosa

Investigation of the total lipidome from a Zoantharia palythoa sp

Lipidomes of phylogenetically different 915 symbiotic dinoflagellates of corals

Coral lipidomes and their changes during coral bleaching

Application of 1H-920 NMR metabolomic profiling for reef-building corals

Metabolomic signatures of 923 increases in temperature and ocean acidification from the reef-building coral, Pocillopora 924 damicornis

Correspondence of 926 coral holobiont metabolome with symbiotic bacteria, archaea and Symbiodinium 927 communities

A unique 929 approach to monitor stress in coral exposed to emerging pollutants

Proposed minimum reporting standards for chemical analysis Chemical Analysis Working 933

Group (CAWG) Metabolomics Standards Initiative (MSI)

Membrane lipids of symbiotic algae are diagnostic of sensitivity to thermal 937 bleaching in corals

Local dynamics of a white syndrome outbreak 941 and changes in the microbial community associated with colonies of the scleractinian brain 942 coral Pseudodiploria strigosa

Disease 944 Diagnostics and Potential Coinfections by Vibrio coralliilyticus During an Ongoing Coral 945 Disease Outbreak in Florida

Unsupervised discovery and comparison of structural families across multiple 949 samples in untargeted metabolomics

Deciphering coral disease dynamics: integrating host, microbiome, and the changing 953 environment

Recent developments in environmental metabolomics

Spatial analyses of benthic habitats to define coral reef ecosystem regions and 957 potential biogeographic boundaries along a latitudinal gradient

Southeast Florida reef-wide Post-Irma coral disease surveys

SE FL ECA reef-building-coral disease 962 intervention and preparation for restoration: Final Report. Florida DEP

Mapping coral reef habitats in southeast Florida 964 using a combined technique approach

Optimizing Stony 967 Coral Tissue Loss Disease (SCTLD) Intervention Treatments on Montastraea cavernosa in 968 an Endemic Zone

Impacts of a regional, multi-year, multi-species 970 coral disease outbreak in southeast Florida

Sharing and 973 community curation of mass spectrometry data with Global Natural Products Social 974 molecular networking

Metabolomic shifts associated with heat stress in coral holobionts

Metabolomics for investigating physiological and pathophysiological 979 processes

A new 981 vitamin E (α-Tocomonoenol) from eggs of the pacific salmon Oncorhynchus keta